EXHIBIT 10.2

 

NONCOMPETE AGREEMENT

 

This NONCOMPETE AGREEMENT (this “Agreement”), dated as of April 26, 2012 is between Array BioPharma Inc., a Delaware corporation (the “Company”), which for the purposes hereof shall include any subsidiary or affiliate of the Company, and Ron Squarer (the “Employee”).

 

RECITALS

 

A.        Employee is or may be employed in an executive, management or professional capacity for the Company.

 

B.        The Employee and Company have entered into that certain Employment Agreement dated at or around the date hereof (the “Employment Agreement”).

 

C.        In order to protect the trade secrets and confidential information of the Company and as a condition to employment or the continued employment (as the case may be) of Employee, the Company requires that Employee enter into this Agreement.

 

NOW THEREFORE, in consideration of Employee’s employment with the Company and of the mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

AGREEMENT

 

1.        Covenants Not to Compete or Interfere.

 

(a)           During the term of Employee’s employment with the Company and for a period of 12 months thereafter, but only if Employee is both terminated pursuant to Sections 5(b) or 5(d) of the Employment Agreement and the Company actually makes payments of benefits contemplated by Section 5(e) of the Employment Agreement (it being agreed that this restriction shall not be applicable should Employee waive rights to such benefits), Employee shall not, within the United States or within a 50 mile radius of any area where the Company is doing business (including any point of sale of the Company’s products or services) at the time of such termination, directly or indirectly own, manage, operate, control, be employed by, serve as a consultant to or otherwise participate in any business (a “Competitive Business”) involving the manufacturing, development and commercialization of small molecule, targeted pharmaceutical products for use in the treatment of inflammation and/or cancer; provided, however that (i) a Competitive Business shall only include products for which the Company has substantial development and commercialization rights (it being agreed that with respect to a collaboration or joint venture, the activities that shall be restricted hereunder are only the activities being performed by the Company or for which the Company has the contractual right to perform under the applicable joint venture or collaboration agreement), (ii) a Competitive Business shall only include products with the same mechanism as those of the Company, subject to this proviso, (iii) a Competing Business shall only include products involving the same stage of tumor or disease and line of therapy (collectively, “Target Population”) as that of a product of the Company where either (x) the Company has run a clinical trial with the same mechanism in patients for the same Target Population (not a so called “all comers” trial) and such development program is not either dormant or abandoned or (y) the Company’s product has been approved and is still being commercialized, (iv) a Competitive Business shall not include products of the Company whose original composition of matter patent, or regulatory exclusivity is expected to expire (or has already expired) prior to such competing product entering the related market, (v) a Competing Business shall not include products that are expected to be used, or are used, as adjuvant (or add on) therapy to the Company’s product that do not otherwise fall within this Section 1(a), (vi) 

 











 

Employee shall not be deemed in violation of this restriction to the extent he is employed by or consults with a company or business that generates less than 10% of its aggregate annual revenues from a Competing Business at the time of initial employment or consultancy and (vii) Employee shall not be deemed in violation of this restriction to the extent he only owns a passive investment equity interest in a company engaged in a Competing Business.

 

(b)       During the term of Employee’s employment with the Company and for a period of 12 months thereafter, and regardless of the reason for Employee’s termination, Employee shall not (i) cause or attempt to cause any employee of the Company to leave the employ of the Company, (ii) actively recruit any employee of the Company to work for any organization of, or in which Employee is an officer, director, employee, consultant, independent contractor or owner of an equity interest; (iii) for purposes of engaging in activities deemed restricted by virtue of Section 1(a) above and only to the extent thereof (regardless of whether 1(a) is not effective by virtue of Employee’s waiver of severance benefits under the Employment Agreement), solicit the business or patronage of any client, customer or account, or prospective client, customer or account, of the Company which were contacted, solicited or served by Employee while employed by the Company; provided, however, that the references to “client, customer or account” within this item (iii) shall not be applicable to wholesalers, GPOs, doctors or pharmacy chains as such reference is intended to refer only to the Company’s collaboration partners; or (iv) divert or take away, or attempt to take away, the business or patronage of any client, customer or account, or prospective client, customer or account, of the Company which were contacted, solicited or served by Employee while employed by the Company; provided, however, that the mere solicitation and selling of products permitted under 1(b)(iii) will not, in and of itself, be deemed to be “diverting”, “taking away” or “attempting to take away” business or patronage under this (iv).

 

(c)       Employee acknowledges that through his employment with the Company he will acquire access to information suited to immediate application by a business in competition with the Company.  Accordingly, Employee considers the foregoing restrictions on his future employment or business activities in all respects reasonable.  Employee specifically acknowledges that the Company and its licensees, as well as the Company’s competitors, provide their services throughout the geographic area specified in Section 1(a) above.  Employee therefore specifically consents to the foregoing geographic restriction on competition and believes that such a restriction is reasonable, given the scope of the Company’s business and the nature of Employee’s position with the Company.

 

(d)       Employee acknowledges the following provisions of Colorado law, set forth in Colorado Revised Statutes § 8-2-113(2):

 

Any covenant not to compete which restricts the right of any person to receive compensation for performance of skilled or unskilled labor for any employer shall be void, but this subsection (2) shall not apply to:

 

(a)                     Any contract for the purchase and sale of a business or the assets of a business;

 

(b)                     Any contract for the protection of trade secrets;

 

(c)                      Any contract provision providing for the recovery of the expense of educating and training an employee who has served an employer for a period of less than two years;

 

(d)                     Executive and management personnel and officers and employees who constitute professional staff to executive and management personnel.

 

Employee acknowledges that this Agreement is a contract for the protection of trade secrets under § 8-2-113(2)(b), and is intended to protect the confidential information and trade secrets of the Company, and that Employee is an executive and management employee or professional staff to executive or management personnel, within the meaning of § 8-2-113(2)(d).

 











 

2.        No Employment Contract; Termination.  This Agreement is not an employment contract and by execution hereof the parties do not intend to create an employment contract.  If, through no fault of Employee, the Company liquidates substantially all of its assets, or permanently terminates its operations, Employee’s obligations under Paragraphs 1(a) and 1(b) shall also terminate.

 

3.        Injunctive Relief; Damages.  Upon a breach or threatened breach by Employee of any of the provisions of this Agreement, the Company shall be entitled to an injunction restraining Employee from such breach without posting a bond.  Nothing herein shall be construed as prohibiting the Company from pursuing any other remedies for such breach or threatened breach, including recovery of damages from Employee.

 

4.        Attorney’s Fees.  In any action to enforce any of the provisions of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees and costs of investigation and litigation.

 

5.        Severability.  It is the desire and intent of the parties that the provisions of this Agreement shall be enforced to the fullest extent permissible under the law.  Accordingly, if any provision of this Agreement shall prove to be invalid or unenforceable, the remainder of this Agreement shall not be affected thereby, and in lieu of each provision of this Agreement that is illegal, invalid or unenforceable, there shall be added as a part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible and be legal, valid and enforceable.  In the event that a court finds any portion of Section 1 to be overly broad, and therefore unenforceable, the parties intend that the court shall modify such portion of paragraph 1 to reflect the maximum restraint allowable, and shall enforce this Agreement and the covenants herein as so modified.

 

6.        Entire Agreement; Governing Law.  This Agreement embodies the entire Agreement between the parties concerning the subject matter hereof and replaces and supersedes any prior or contemporaneous negotiations, oral representations, agreements or understandings among or attributable to the parties hereto.  The provisions of this Agreement shall not limit or otherwise affect Employee’s obligations under the provisions of any agreement with the Company with respect to the nondisclosure of the Company’s confidential information.  This Agreement and all performances hereunder shall be governed by and construed in accordance with the laws of the State of Colorado.

 

7.        Consent to Jurisdiction.  All judicial proceedings brought against Employee arising out of or relating to this Agreement may be brought in any state or federal court of competent jurisdiction in this State of Colorado, and by execution and delivery of this Agreement, Employee accepts the nonexclusive jurisdiction of the aforesaid courts and waives any defense of forum non convenient  and irrevocably agrees to be bound by any judgment rendered thereby in connection with this Agreement.

 

8.        Waiver of Jury Trial.  Employee and the Company hereby agree to waive their respective rights to a jury trial of any claim or cause of action based upon or arising out of this Agreement.  The scope of this waiver is intended to be all encompassing of any and all disputes that may be filed in any court and that relate to the subject matter of this Agreement, including without limitation, contract claims, tort claims, breach of duty claims, and all other common law and statutory claims.  Employee and the Company warrant and represent that each has reviewed this waiver with its legal counsel and that each knowingly and voluntarily waives its jury trial rights following consultation with legal counsel.  In the event of litigation, this Agreement may be filed as a written consent to a trial by the court.

 

9.        Amendments; Waiver.  This Agreement may not be altered or amended, and no right hereunder may be waived, except by an instrument executed by each of the parties hereto.  No waiver of any term, provision, or condition of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision or condition of this Agreement.

 











 

10.      Assignment.  The Company may assign its rights and obligations under this Agreement to any subsidiary or affiliate of the Company or to any acquirer of substantially all of the business of the Company, and all covenants and Agreements hereunder shall inure to the benefit of and be enforceable by or against any such assignee.  Neither this Agreement nor any rights or duties hereunder may be assigned or delegated by Employee.

 

11.      Binding Effect.  Except as otherwise provided herein, this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective legal representatives, heirs, successors and assigns.

 











 

IN WITNESS WHEREOF the parties have executed this Agreement as of the date first above written.

 

	
COMPANY:
    	
ARRAY BIOPHARMA INC.,
    
	
 
    	
 
    	
a Delaware   corporation
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
/s/ Kyle Lefkoff
    
	
 
    	
 
    	
Kyle Lefkoff
    
	
 
    	
 
    	
Chairman, Board of Directors
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
EMPLOYEE:
    	
 
    	
/s/ Ron Squarer
    
	
 
    	
 
    	
Ron Squarer